Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptor

The **Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors** are subtypes of adrenergic (adrenoceptor) family, which are G protein-coupled receptors that mediate the actions of catecholamines such as norepinephrine and epinephrine throughout the body[1][3][4]. Alpha-1 receptors primarily cause smooth muscle contraction (vasoconstriction), alpha-2 receptors inhibit neurotransmitter release and lower sympathetic outflow, beta-1 receptors increase heart rate and cardiac contractility, and beta-2 receptors promote bronchodilation and relax smooth muscle in various tissues[1][3]. These receptors serve as key pharmacological targets for cardiovascular, respiratory, and neuropsychiatric diseases, and are modulated by a wide range of agonist and antagonist drugs commonly used in clinical practice[1][2][3][5]. **Note:** - **is_incorrect: true** because combining all four subtypes as a single target is not standard; these are four distinct but related receptors, each with its own canonical name, gene, and pharmacology. For structured databases, each should be considered separately (e.g., Alpha-1 adrenergic receptor, Beta-2 adrenergic receptor)[1][3][4][6].

Other names

AdrenoceptorAdrenergic receptorα1-adrenergic receptorα2-adrenergic receptorβ1-adrenergic receptorβ2-adrenergic receptor

Agonists activate receptor-mediated signal transduction (increasing or decreasing physiological activity depending on subtype and tissue) Antagonists block catecholamine binding, reducing sympathetic activity Partial agonists partially stimulate the receptor while blocking stronger agonist effects